MW2022-06-22 - A multicenter prospective randomized double blind placebo controlled adaptive design study performed to evaluate the efficacy and the safety of EscharEx in debridement of Venous Leg Ulcers (VALUE)

Brief description of study

The purpose of this research study is to evaluate the efficacy and safety of the investigational drug EscharEx (EX-03) to break down damaged tissue (debridement) of a venous leg ulcer without affecting healthy tissue, and to assess how EX-03 is tolerated.

Clinical Study Identifier: s24-01626

ClinicalTrials.gov Identifier: NCT06568627

Principal Investigator: Scott A Gorenstein.

Other Investigators: Patrick Jasinski, Maria Esther Umanzor, Armon Panahi, Pauline Muscat, Chiagozie Nwakanma.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies